The latest update is out from Axsome Therapeutics ( (AXSM) ).

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous ...

Velo names SRAM Force AXS the 2025 Product of the Year. It offers the exact same performance as the top-tier RED groupset for ...

New Drug Application (NDA) submission on track for January 2026NEW YORK, Dec. 31, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: ...

While the Casey's Center won't host any concerts in January, there are dozens to choose from at Hoyt Sherman Place, Wooly's, ...

From the Netflix smash hit Stranger Things to the addicting HBO Max medical series The Pitt, these TV shows are perfect to ...

Hip hop, rock, R&B, pop and country artists will all visit Kansas City throughout 2026. See who all is coming to town.

Axsome Therapeutics (AXSM) stock gains as the FDA grants priority review to expand its depression drug Auvelity for Alzheimer ...

Axsome just received priority review designation for its most important drug. Auvelity is an oral medication already approved ...

New Drug Application (NDA) submission on track for January 2026 NEW YORK, Dec. 31, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in ...